By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Following through on a plan it made public last week in connection with its $5.7 billion hostile takeover bid for Illumina, Roche today has published the names of the people it will nominate to serve on Illumina's board of directors.
Registering provides access to this and other free content.
Already have an account?Login Now.
By analyzing tweets, Canadian researchers examine the public's view of gene patenting.
In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.
Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.
Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.